Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Lundgren

Showing results (561-570 of 681) with videos related to

Pageof 69
Sort By:
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|June 15, 2010
Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs studyNina Friis-Møller, Rodolphe Thiébaut, Peter Reiss, et al.
Journal of the International AIDS Society|June 29, 2019
Incomplete ART adherence is associated with higher inflammation in individuals who achieved virologic suppression in the START studyJose R Castillo-Mancilla, Andrew N Phillips, James D Neaton, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 23, 2019
Epidemiology of hepatitis E virus infection in a cohort of 4023 immunocompromised patientsLene H Harritshøj, Christoffer E Hother, Henrik Sengeløv, et al.
Metabolites|September 27, 2023
Metabolic Profiling Early Post-Allogeneic Haematopoietic Cell Transplantation in the Context of CMV InfectionKirstine K Rasmussen, Quenia Dos Santos, Cameron Ross MacPherson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 8, 2008
Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction, C A Sabin, A d'Arminio Monforte, et al.
Epidemiology (Cambridge, Mass.)|April 28, 2011
The Coding Causes of Death in HIV (CoDe) Project: initial results and evaluation of methodologyJustyna D Kowalska, Nina Friis-Møller, Ole Kirk, et al.
AIDS (London, England)|August 7, 2019
Serious clinical events in HIV-positive persons with chronic kidney diseaseLene Ryom, Jens D Lundgren, Matthew Law, et al.
Antiviral Therapy|May 29, 2008
Interruption of antiretroviral therapy and risk of cardiovascular disease in persons with HIV-1 infection: exploratory analyses from the SMART trialAndrew N Phillips, Andrew Carr, Jacquie Neuhaus, et al.
HIV Medicine|May 21, 2014
Increased risk of cardiovascular disease (CVD) with age in HIV-positive men: a comparison of the D:A:D CVD risk equation and general population CVD risk equationsK Petoumenos, P Reiss, L Ryom, et al.
The Lancet. Global Health|September 21, 2023
Potential cost-effectiveness of community availability of tenofovir, lamivudine, and dolutegravir for HIV prevention and treatment in east, central, southern, and west Africa: a modelling analysisAndrew N Phillips, Loveleen Bansi-Matharu, Maryam Shahmanesh, et al.
Pageof 69

Showing results (561-570 of 681) with videos related to

Sort By:
Pageof 69
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|June 15, 2010
Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs studyNina Friis-Møller, Rodolphe Thiébaut, Peter Reiss, et al.
Journal of the International AIDS Society|June 29, 2019
Incomplete ART adherence is associated with higher inflammation in individuals who achieved virologic suppression in the START studyJose R Castillo-Mancilla, Andrew N Phillips, James D Neaton, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 23, 2019
Epidemiology of hepatitis E virus infection in a cohort of 4023 immunocompromised patientsLene H Harritshøj, Christoffer E Hother, Henrik Sengeløv, et al.
Metabolites|September 27, 2023
Metabolic Profiling Early Post-Allogeneic Haematopoietic Cell Transplantation in the Context of CMV InfectionKirstine K Rasmussen, Quenia Dos Santos, Cameron Ross MacPherson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 8, 2008
Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction, C A Sabin, A d'Arminio Monforte, et al.
Epidemiology (Cambridge, Mass.)|April 28, 2011
The Coding Causes of Death in HIV (CoDe) Project: initial results and evaluation of methodologyJustyna D Kowalska, Nina Friis-Møller, Ole Kirk, et al.
AIDS (London, England)|August 7, 2019
Serious clinical events in HIV-positive persons with chronic kidney diseaseLene Ryom, Jens D Lundgren, Matthew Law, et al.
Antiviral Therapy|May 29, 2008
Interruption of antiretroviral therapy and risk of cardiovascular disease in persons with HIV-1 infection: exploratory analyses from the SMART trialAndrew N Phillips, Andrew Carr, Jacquie Neuhaus, et al.
HIV Medicine|May 21, 2014
Increased risk of cardiovascular disease (CVD) with age in HIV-positive men: a comparison of the D:A:D CVD risk equation and general population CVD risk equationsK Petoumenos, P Reiss, L Ryom, et al.
The Lancet. Global Health|September 21, 2023
Potential cost-effectiveness of community availability of tenofovir, lamivudine, and dolutegravir for HIV prevention and treatment in east, central, southern, and west Africa: a modelling analysisAndrew N Phillips, Loveleen Bansi-Matharu, Maryam Shahmanesh, et al.
Pageof 69